News Daily News JACC Debuts Data Digest on CV Health in the United States Caitlin E. Cox January 12, 2026
News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2025 Michael O'Riordan December 29, 2025
News Conference News AHA 2025 POLY-HF: Polypill Pays Dividends in Patients With HFrEF Todd Neale November 14, 2025
News Features Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile Michael O'Riordan October 17, 2025
News Daily News Recognize and Enable Care for Post-MI Psychological Distress: AHA L.A. McKeown October 01, 2025
News Conference News HFSA 2025 Lowering Novel Biomarker, GDF-15, Raises HF Event Rate: GARDEN-TIMI 74 Yael L. Maxwell September 30, 2025
News Conference News HFSA 2025 CCM-D Delivers Safe, Effective Integrated Therapy in HFrEF Yael L. Maxwell September 29, 2025
News Conference News HFSA 2025 Voice Analysis Picks Up Patients at Risk for HF Hospitalization: COMMUNITY-HF Yael L. Maxwell September 29, 2025
News Daily News CVD Still the Leading Cause of Death and Disease Globally Michael O'Riordan September 24, 2025
News Conference News ESC 2025 PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy Michael O'Riordan September 01, 2025
News Daily News Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data L.A. McKeown July 24, 2025
News Daily News AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review Todd Neale July 24, 2025
News Conference News NY Valves 2025 MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed Yael L. Maxwell July 03, 2025